专利检索 ap:("PROMETHEUS BIOSCIENCES, INC." OR "CEDARS-SINAI MEDICAL CENTER") AND inv:"Matthew Reissman" 第 1 页

1.

发明授权
Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof 有权

公开(公告)号：US11999789B2

公开(公告)日：2024-06-04

申请号：US17682922

申请日：2022-02-28

申请人： PROMETHEUS BIOSCIENCES, INC. , CEDARS-SINAI MEDICAL CENTER

发明人： Jeffry D. Watkins , Cindy T. Dickerson , Rafael Rojas , Matthew Reissman , Patricia McNeeley , Janine Bilsborough , Bradley Henkle , Stephan R. Targan

IPC分类号： C07K16/24 , A61P1/04 , C07K16/28 , A61K39/395 , C07K14/52 , C07K14/525

CPC分类号： C07K16/2875 , A61P1/04 , C07K16/241 , C07K2317/21 , C07K2317/24 , C07K2317/40 , C07K2317/51 , C07K2317/515 , C07K2317/56 , C07K2317/76

摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

2.

发明申请
HUMANIZED ANTIBODIES TO TNF-LIKE LIGAND 1A (TL1A) AND USES THEREOF 有权

公开(公告)号：US20220259320A1

公开(公告)日：2022-08-18

申请号：US17682922

申请日：2022-02-28

申请人： PROMETHEUS BIOSCIENCES, INC. , CEDARS-SINAI MEDICAL CENTER

发明人： Jeffry D. Watkins , Cindy T. Dickerson , Rafael Rojas , Matthew Reissman , Patricia McNeeley , Janine Bilsborough , Bradley Henkle , Stephan R. Targan

IPC分类号： C07K16/28 , A61P1/04 , C07K16/24

摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

3.

发明公开
HUMANIZED ANTIBODIES TO TNF-LIKE LIGAND 1A (TL1A) AND USES THEREOF 审中-公开

公开(公告)号：US20240327532A1

公开(公告)日：2024-10-03

申请号：US18645261

申请日：2024-04-24

申请人： PROMETHEUS BIOSCIENCES, INC. , CEDARS-SINAI MEDICAL CENTER

发明人： Jeffry D. Watkins , Cindy T. Dickerson , Rafael Rojas , Matthew Reissman , Patricia McNeeley , Janine Bilsborough , Bradley Henkle , Stephan R. Targan

IPC分类号： C07K16/28 , A61P1/04 , C07K16/24

CPC分类号： C07K16/2875 , A61P1/04 , C07K16/241 , C07K2317/21 , C07K2317/24 , C07K2317/40 , C07K2317/51 , C07K2317/515 , C07K2317/56 , C07K2317/76

摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

4.

发明授权
Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof 有权

公开(公告)号：US11292848B2

公开(公告)日：2022-04-05

申请号：US17110004

申请日：2020-12-02

申请人： PROMETHEUS BIOSCIENCES, INC. , CEDARS-SINAI MEDICAL CENTER

发明人： Jeffry D. Watkins , Cindy T. Dickerson , Rafael Rojas , Matthew Reissman , Patricia McNeeley , Janine Bilsborough , Bradley Henkle , Stephan R. Targan

IPC分类号： C07K16/24 , C07K16/28 , A61P1/04 , C07K14/52 , C07K14/525 , A61K39/395

摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

5.

发明申请
HUMANIZED ANTIBODIES TO TNF-LIKE LIGAND 1A (TL1A) AND USES THEREOF 有权

公开(公告)号：US20210122828A1

公开(公告)日：2021-04-29

申请号：US17110004

申请日：2020-12-02

申请人： PROMETHEUS BIOSCIENCES, INC.

发明人： Jeffry D. Watkins , Cindy T. Dickerson , Rafael Rojas , Matthew Reissman , Patricia McNeeley

IPC分类号： C07K16/28 , A61P1/04

摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).